Biotech · Private company
Regenerative Ocular Immunobiologics LLC
Track this companyFree. Adds Regenerative Ocular Immunobiologics LLC to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- d-MAPPS™ Ophthalmic SolutionPhase 3 · oGVHDClinicalTrials.gov · fetched Nov 12, 2026
- Matching vehicle controlPhase 3 · oGVHDClinicalTrials.gov · fetched Nov 12, 2026
- d-MAPPSPhase 2 · oGHVDClinicalTrials.gov · fetched Nov 12, 2026
- PI and Patient MaskedPhase 2 · oGHVDClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of d-MAPPS™ Ophthalmic Solution in Adults With Chronic Ocular Graft-Versus-Host Disease (oGVHD)PHASE3 · RECRUITING · started Sep 8, 2026ClinicalTrials.gov NCT07776210 · fetched Nov 12, 2026
- Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 10, 2025ClinicalTrials.gov NCT06852768 · fetched Nov 12, 2026